Zuellig Pharma Singapore and GSK Establish Vaccine Distribution Hub to Improve Asia’s Access to Vaccines

.

 

SINGAPORE - Radar Seluma.Disway.Id - Zuellig Pharma, one of the largest healthcare services groups in Asia, today announced that it has entered into an agreement with global biopharma company, GSK, to help set up its first vaccine distribution hub in the region. The vaccine distribution hub will be headquartered in Singapore, serving 13 markets in Asia-Pacific (APAC).

 

BACA JUGA:Setelah Lisensi Miss Universe Indonesia Dicabut. Fabienne Nicole Tetap Diakui dan Ikut Miss Universe

Under the partnership, Zuellig Pharma Singapore will provide GSK with warehousing and distribution services in cold-chain management for its vaccines. The vaccine hub will also leverage Zuellig Pharma's expertise in blockchain technology for China, one of GSK's largest APAC markets. The use of eZTracker, Zuellig Pharma's end-to-end blockchain solution, will enhance the resiliency of GSK's supply chain to enable greater traceability of its vaccines. This allows for better product visibility to address the growing challenge of counterfeit healthcare products in Asia.

 

The vaccine distribution hub will adopt a sea transport model to reduce its supply chain carbon footprint, resulting in reduced transportation carbon emissions by at least 30%, compared to air transport. All vaccines will also be under vigorous temperature control to safeguard their integrity and quality.

 

Tan Yan Ann, Chief Executive, Zuellig Pharma Singapore said: "GSK has been a long-term partner of Zuellig Pharma with a strong focus on improving patients' access to healthcare. We are delighted to be able to support them in the management of their Asia supply chain. With each market having their own unique requirements, the strategic location of GSK's vaccine hub will allow it to respond quickly to the changing healthcare landscape. Combining our cold chain expertise and proven blockchain solution, we look forward to building a stronger and more resilient supply chain with GSK to make healthcare more accessible in the communities we serve in the region."

 

Robert Kruit, EVP Strategic Partnerships & Business Development, Zuellig Pharma said: "With the launch of GSK's regional vaccine distribution hub, the strategic partnership between GSK and Zuellig Pharma delivers a profound, direct impact on vaccine availability in the region, while reducing the carbon footprint and setting a standard in supply chain traceability."

 

GSK's vaccines portfolio is the broadest in the biopharma industry, helping protect people from diseases such as meningitis, shingles, flu, polio, measles and many more. Two million of the company's vaccines are administered every day, including to 40% of the world's children who receive a GSK vaccine each year.1

Sumber: